Medical Device Testing Services Market Size

ID: MRFR/MED/10831-HCR

131 Pages

Rahul Gotadki

October 2025

Medical Device Testing Services Market Research Report Information By Services (Biocompatibility Tests, Chemistry Test and Microbiology & Sterility Test), By Phase (Preclinical and Clinical) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World), Forecast Till 2035

Medical Device Testing Services Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Download PDF

Medical Device Testing Services Size

Market Size Snapshot

Year	Value
2025	USD 11.1 Billion
2034	USD 24.71 Billion
CAGR (2025-2034)	9.3 %

Note – Market size depicts the revenue generated over the financial year

The medical devices testing services market is expected to grow at a CAGR of about 7% from now to 2025, and it is expected to reach $24.7 billion by 2034. This growth rate represents a strong CAGR of 9.3 percent from now to 2025. Increasing demand for medical devices and stringent regulatory requirements have led to the need for comprehensive testing to ensure their safety and effectiveness. As patient safety and product reliability continue to be the top priorities of health care systems worldwide, the market is experiencing a significant surge in investment and the development of new testing methods. This upward trend is due to several factors, including the rapid development of medical devices technology, such as the integration of artificial intelligence and the Internet of Things, which requires more sophisticated testing methods. Also, the growing number of chronic diseases and the aging of the population are driving the demand for advanced medical solutions, which is boosting the demand for testing services. The major players in the market, such as SGS SA, Intertek Group, and Eurofins Scientific, are focusing on strategic initiatives, such as mergers and acquisitions, to strengthen their service offerings and market positions. Recent collaborations to develop new testing methods also indicate the industry's commitment to ensuring compliance with changing regulatory requirements and enhancing patient safety.

home-ubuntu-www-mrf_ne_design-batch-6-cp-medical-device-testing-services-market size

Regional Market Size

Regional Deep Dive

The medical device testing services market is experiencing considerable growth across all regions, owing to the increasing regulatory requirements, technological advancements, and the growing demand for novel medical devices. North America is characterized by a strong health care system and a high concentration of leading medical device manufacturers, while Europe is characterized by stringent regulations to ensure high-quality standards. The Asia-Pacific region is expected to grow at a high rate, owing to the increasing availability of health care and the increasing investment in medical technology. The Middle East and Africa are gradually developing their testing capabilities, while Latin America is focusing on regulatory compliance to enhance its market potential.

Europe

The implementation of the Medical Device Regulation (MDR) in the EU has led to increased demand for testing services, as manufacturers must comply with more stringent requirements for safety and efficacy.
Organizations such as TÜV SÜD and BSI are enhancing their testing capabilities to support manufacturers in navigating the complex regulatory landscape, which is expected to drive innovation in testing methodologies.

Asia Pacific

Countries like China and India are investing heavily in healthcare infrastructure, leading to a surge in demand for medical device testing services as local manufacturers seek to meet international standards.
The rise of telemedicine and digital health solutions in the region is prompting testing services to adapt to new technologies, with companies like SGS and Eurofins expanding their offerings to include software and cybersecurity testing.

Latin America

Regulatory bodies in Brazil and Mexico are working to harmonize their medical device regulations with international standards, which is increasing the demand for accredited testing services.
Local companies are beginning to invest in advanced testing technologies, with firms like DNV GL expanding their presence in the region to support the growing need for compliance and quality assurance.

North America

The FDA has recently updated its guidelines for medical device testing, emphasizing the need for more rigorous pre-market evaluations, which is pushing companies to seek comprehensive testing services.
Key players like UL and Intertek are expanding their testing facilities in North America to accommodate the growing demand for advanced medical device testing, particularly in areas like biocompatibility and cybersecurity.

Middle East And Africa

The establishment of the Gulf Cooperation Council (GCC) regulatory framework is enhancing the standardization of medical device testing in the region, encouraging local manufacturers to improve their testing processes.
Collaborations between local governments and international testing organizations are emerging, such as the partnership between the UAE Ministry of Health and WHO, aimed at improving medical device safety and efficacy.

Did You Know?

“Approximately 70% of medical device recalls are due to design flaws, highlighting the critical importance of thorough testing services in ensuring device safety and efficacy.” — FDA Medical Device Recall Data

Segmental Market Size

The medical devices testing business plays a key role in ensuring the safety and efficacy of medical devices. It is currently experiencing a period of steady growth. Demand is being driven by the strict regulatory requirements of the FDA and EMA, which require devices to be tested thoroughly to ensure that they meet safety standards. Moreover, the increasing complexity of medical devices, especially in the field of wearables and implantables, is driving the need for increasingly sophisticated testing to verify performance and reliability. TÜV SÜD and Intertek are currently the leading companies in this field, offering a comprehensive range of testing solutions. Biocompatibility testing, electrical safety testing and software testing are the most important applications in regions where the regulatory framework is well established, such as North America and Europe. The trend towards telehealth and remote monitoring devices, which was further fuelled by the pandemic of CovId-X9, is also driving growth in this field. Artificial intelligence and machine learning are also influencing the development of testing procedures, enabling the testing process to be performed more quickly and accurately.

Future Outlook

The Medical Device Testing Services Market is set to grow at a robust CAGR of 9.3 per cent from 2025 to 2034. The escalating complexity of medical devices, which require rigorous testing to ensure safety and efficacy, will fuel this growth. The regulatory authorities in the world, such as the Food and Drug Administration and the European Medicines Agency, are expected to further tighten their compliance standards, thus driving up the demand for comprehensive testing services. By 2034, it is expected that over 70 per cent of medical device manufacturers will be using third-party testing services to meet regulatory requirements, a rise from an estimated 50 per cent in 2025. Furthermore, technological advancements, especially in the fields of biocompatibility testing, software validation, and cyber security testing, will further shape the landscape of the medical device testing services market. Artificial intelligence and machine learning in the testing procedures will improve their efficiency and accuracy, thus enabling the devices to reach the market more quickly. The growing demand for digitized health devices, and the rise of the Internet of Things, will create new testing requirements, which will necessitate specialized testing services. The market players will have to remain agile to take advantage of the expanding opportunities in this rapidly evolving market.

Medical Device Testing Services Market Size Graph

Market Highlights

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future Analysis, the Medical Device Testing Services Market was valued at 10.15 USD Billion in 2024 and is projected to grow to 27.01 USD Billion by 2035, with a CAGR of approximately 9.30% from 2025 to 2034. The market is driven by stringent regulatory requirements, the increasing complexity of medical devices, and the need for risk mitigation. Key regulatory bodies, such as the FDA and EMA, enforce rigorous testing standards to ensure patient safety and device efficacy. The market is characterized by a growing trend towards global harmonization of regulations, necessitating consistent testing services across regions.

Key Market Trends & Highlights

The Medical Device Testing Services Market is influenced by several key trends.

Market Size in 2024: 10.15 USD Billion; Expected to reach 27.01 USD Billion by 2035. CAGR from 2025 to 2034: Approximately 9.30%; driven by stringent regulatory requirements. Microbiology & Sterility Tests segment holds 34.2% revenue share in 2022; critical for patient safety. Clinical phase dominates with over 68.8% revenue share in 2022; essential for regulatory approval.

Medical Device Testing Services Market

CAGR

9.30%

Market Size & Forecast

2024 Market Size	USD 10.15 Billion
2035 Market Size	USD 27.01 Billion
CAGR (2025-2035)	9.30%
Largest Regional Market Share in 2022	North America.

Major Players

SGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Charles River Laboratories; Sterigenics International LLC; Eurofins Scientific; Intertek Group Plc.

Market Trends

Stringent regulatory requirements and standards are driving the market growth.

Market CAGR for medical device testing services is being driven by the rising stringent regulatory requirements and standards. Medical devices are subject to rigorous testing and quality assurance processes to make sure they are safe and effective for patient use. Advances in medical device technology leading to the development of increasingly complex devices, such as implantable devices, diagnostic equipment and digital health solutions. Comprehensive testing is essential to ensure the safety, reliability and performance of these complex devices.

Regulatory bodies, like the US Food and the Drug Administration (FDA) in the US and European Medicine Agency (EMA) in Europe, mandate thorough testing to protect patient safety. As regulations evolve and become more stringent, manufacturers increasingly rely on testing services to meet compliance requirements. There is a growing trend toward the global harmonization of medical device regulations, like the International Medical Device Regulators Forum (IMDRF) and the Medical Device Single Audit Program (MDSAP). These initiatives encourage standardized testing and quality standards across different regions, driving the need for consistent testing services.

Further, manufacturers and healthcare organizations seek to mitigate risks associated with medical devices, including recalls and adverse events. In order to bring medical devices to market, manufacturers must demonstrate compliance with regulatory requirements. Testing services provide the necessary evidence of safety and efficiency, facilitating market entry and regulatory approvals.

High-quality testing services help manufacturers maintain their reputation and credibility by ensuring that their products meet the highest standards. Ongoing innovation in medical device technology necessitates continuous testing and validation of new features and capabilities. After a medical device is on the market, ongoing surveillance and testing are required to monitor its performance, detect issues and make improvements. Further, medical device manufacturers often expand their market presence internationally. This expansion requires compliance with various regional and national regulations, driving the need for testing services that can address diverse regulatory requirements.

A growing focus on patient-centered healthcare emphasizes the importance of safe and effective medical devices. Rigorous testing ensures that devices meet the expectations of healthcare providers and patients. The primary objective of strict approval norms is to ensure the safety of the patients and users of medical devices. Additionally, adherence to strict approval norms helps minimize the likelihood of product recalls and legal liabilities for manufacturers. Thus driving the Medical Device Testing Services market revenue.

The increasing complexity of medical devices necessitates a robust testing framework to ensure safety and efficacy, reflecting a growing emphasis on regulatory compliance and patient outcomes.

U.S. Food and Drug Administration (FDA)

Medical Device Testing Services Market Market Drivers

Increasing Regulatory Compliance Requirements

The Global Medical Device Testing Services Market Industry is experiencing heightened scrutiny from regulatory bodies, necessitating rigorous testing protocols. As governments worldwide implement stricter regulations to ensure patient safety and product efficacy, manufacturers are compelled to invest in comprehensive testing services. This trend is particularly evident in regions like North America and Europe, where compliance with standards such as ISO 13485 and FDA regulations is paramount. The growing emphasis on regulatory compliance is likely to drive the market's expansion, as companies seek to avoid costly recalls and legal repercussions, thereby contributing to the projected market value of 10.2 USD Billion in 2024.

Market Segment Insights

Medical Device Testing Services Service Insights

The Medical Device Testing Services Market segmentation, based on service, includes Biocompatibility Tests, Chemistry Tests and Microbiology test and sterility Tests. The microbiology & sterility test segment dominates the market and accounts for 34.2% revenue share in 2022. The dominance of the category is due to their critical role in ensuring the safety and efficacy of medical devices. Regulatory bodies like the FDA and EMA require manufacturers to adhere to stringent microbiological and sterility testing standards. It has an essential role in patient safety, quality control and mitigation of risk and has a diverse application across diverse medical device categories.

The second most popular service is biocompatibility testing, as it is an indispensable service that helps manufacturers assess the compatibility of their devices with the human body.

Medical Device Testing Services Phase Insights

The Medical Device Testing Services Market segmentation, based on phase, includes Preclinical and Clinical. The clinical category dominates the market, accounting for more than 68.8% of revenue in 2022. The regulatory bodies mandate extensive clinical testing for medical devices; in order to gain regulatory approval and market access, manufacturers are required to conduct clinical trials that assess the safety and the efficacy. The clinical phase provides patient safety assurance, efficacy validation, competitive advantage, innovation support, reimbursement and insurance coverage and long-term device performance.

Further, the preclinical phase is expected to attain stable growth due to a growing number of companies investing in the R&D of new medical devices for rare diseases.

Figure 1: Medical Device Testing Services Market, by Phase, 2022 & 2032 (USD Billion)

Get more detailed insights about Medical Device Testing Services Market Research Report 2035

Regional Insights

By region, the study gives market insights into the North America, Europe, Asia-Pacific and the Rest of the World. The North American Medical Device Testing Services market area dominates the market as the region has one of the most stringent and well-established regulatory environments for medical devices. There is a presence of a large medical industry and hub for medical device innovation and technological advancements in this region. North American region has an innovation culture, extensive clinical trial activity, market access opportunities, commitment to quality assurance, access to expertise and global reach of service providers.

Further, the prime countries studied in the market report are The US, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: MEDICAL DEVICE TESTING SERVICES MARKET SHARE BY REGION 2022 (USD Billion)

Source: The Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Medical Device Testing Services market accounts for the second-largest market share as the region has a strong and well-established healthcare infrastructure with advanced hospitals, research centers and healthcare professionals. Further, the German Medical Device Testing Services market held largest market share, and the U.K. Medical Device Testing Services market was the fastest-growing market in the European region.

The Asia-Pacific Medical Device Testing Services Market is expected to rise at the rapid CAGR from 2023 to 2032. This is due to expanding healthcare infrastructure, increasing medical device manufacturing and increased regulatory compliance. Moreover, China’s Medical Device Testing Services market held the largest market revenue, and the Indian Medical Device Testing Services market was the fastest-growing market in the Asia-Pacific region.

Key Players and Competitive Insights

Leading market participants are investing hugely in research and development in order to spread their product lines, which will help the Medical Device Testing Services market grow even more. Market players are also undertaking a variety of strategic activities to spread their global footprint, with important market developments including contractual agreements, new product launches, mergers and acquisitions, higher investments, and collaboration with other organizations. To spread and survive in a more competitive and rising market climate, the Medical Device Testing Services industry must offer cost-effective items.

Manufacturing locally to minimize the operational costs is one of the key business tactics used by the manufacturers in the global Medical Device Testing Services industry to benefit the clients and increase the market sector. In recent years, the Medical Device Testing Services industry has provided some of the most significant advantages to the healthcare industry.

Major participants in the Medical Device Testing Services market, including SGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Charles River Laboratories; Sterigenics International LLC; Element Minnetonka; North America Science Associates Inc.; Eurofins Scientific; Pace Analytical Services LLC; Intertek Group Plc, and others, are attempting to increase the market demand by investing in the research and development operations.

Charles River Laboratories International Inc. is a company that provides a broader range of products and services to support the pharmaceutical, biotechnology and healthcare industries in their research and drug development efforts. Founded in 1947, the company provides a wide range of preclinical research services, including in vivo studies, pharmacology, toxicology and efficacy testing. The company specializes in safety assessment services, which involve assessing the potential risks and safety profiles of new drugs and therapies.

In February 2022, Charles River Laboratories, a leading provider of preclinical research services, announced a partnership with Kibur Medical, a leading provider of implantable microdevice technology. The partnership will enable Charles River Laboratories to offer its clients access to Kibur Medical’s IMD technology for preclinical in-vivo oncology studies.

LabCorp, a leading life sciences company that specializes in diagnostic testing, drug development and clinical trial services. Headquartered in Burlington, North Carolina, LabCorp plays a crucial role in healthcare by providing a wide range of laboratory testing and diagnostic services to patients, healthcare providers, pharmaceutical companies and researchers. In November 2021, LabCorp, a leading provider of clinical laboratory services, announced the acquisition of Toxikon, a leading provider of nonclinical toxicology testing services for medical devices and pharmaceuticals. The acquisition will enable LabCorp to expand its portfolio of medical device testing services to strengthen its position in the preclinical testing market.

Key Companies in the Medical Device Testing Services Market market include

Industry Developments

Q2 2024: Eurofins Medical Device Testing Expands Capabilities with New Laboratory in Singapore Eurofins Medical Device Testing announced the opening of a new laboratory in Singapore to expand its testing capabilities and support medical device manufacturers in the Asia-Pacific region.
Q2 2024: Nelson Labs Announces Acquisition of Gibraltar Laboratories Nelson Labs, a leading provider of microbiological and analytical chemistry testing for medical devices, acquired Gibraltar Laboratories to enhance its service offerings and geographic reach.
Q1 2024: FDA Authorizes New Sterility Testing Protocol for Medical Device Manufacturers The FDA approved a new sterility testing protocol, allowing medical device manufacturers to utilize advanced rapid microbiological methods for regulatory submissions.
Q2 2024: SGS Opens New Medical Device Testing Laboratory in Shanghai SGS, a global testing and certification company, opened a new medical device testing laboratory in Shanghai to meet growing demand for regulatory compliance services in China.
Q1 2024: Intertek Launches Biocompatibility Testing Services for Wearable Medical Devices Intertek announced the launch of specialized biocompatibility testing services tailored for wearable medical devices, addressing the increasing complexity of device materials.
Q2 2024: Element Materials Technology Acquires Nanosafe Inc. Element Materials Technology acquired Nanosafe Inc., a provider of nanotechnology-focused medical device testing, to expand its portfolio in advanced device safety evaluation.
Q1 2024: TÜV SÜD Appoints New CEO for Global Medical Device Testing Division TÜV SÜD announced the appointment of a new CEO to lead its global medical device testing division, aiming to drive innovation and growth in regulatory testing services.
Q2 2024: Medistri Secures ISO 17025 Accreditation for Expanded Medical Device Testing Services Medistri received ISO 17025 accreditation for its expanded medical device testing services, strengthening its position as a certified provider for device manufacturers.
Q1 2024: WuXi AppTec Medical Device Testing Announces Strategic Partnership with Medtronic WuXi AppTec Medical Device Testing entered a strategic partnership with Medtronic to provide comprehensive testing services for Medtronic’s next-generation implantable devices.
Q2 2024: Pace Analytical Launches New Extractables and Leachables Testing Service for Medical Devices Pace Analytical introduced a new extractables and leachables testing service to help medical device manufacturers comply with evolving regulatory requirements.
Q1 2024: Eurofins Medical Device Testing Receives FDA Approval for New Biocompatibility Testing Method Eurofins Medical Device Testing received FDA approval for a novel biocompatibility testing method, enabling faster and more accurate safety assessments for device manufacturers.
Q2 2024: SGS Acquires LabCorp’s Medical Device Testing Division SGS completed the acquisition of LabCorp’s medical device testing division, expanding its global footprint and service capabilities in regulatory testing.

Future Outlook

Medical Device Testing Services Market Future Outlook

The Medical Device Testing Services Market is poised for growth at a 9.30% CAGR from 2025 to 2035, driven by technological advancements, regulatory changes, and increasing demand for innovative medical devices.

New opportunities lie in:

Invest in AI-driven testing technologies to enhance efficiency and accuracy. Expand service offerings to include biocompatibility testing for emerging materials. Develop strategic partnerships with startups to innovate testing methodologies.

By 2035, the market is expected to exhibit robust growth, reflecting evolving industry standards and consumer demands.

Market Segmentation

Medical Device Testing Services Phase Outlook

Preclinical
Clinical

Medical Device Testing Services Service Outlook

Biocompatibility Tests
Chemistry Test
Microbiology & Sterility Test

Medical Device Testing Services Regional Outlook

{""=>["US"
"Canada"]}
{""=>["Germany"
"France"
"UK"
"Italy"
"Spain"
"Rest of Europe"]}
{""=>["China"
"Japan"
"India"
"Australia"
"South Korea"
"Rest of Asia-Pacific"]}
{""=>["Middle East"
"Africa"
"Latin America"]}

Report Scope

Report Attribute/Metric	Details
Market Size 2024	10.15 (USD Billion)
Market Size 2025	11.10 (USD Billion)
Market Size 2035	27.01 (USD Billion)
Compound Annual Growth Rate (CAGR)	9.30% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2020 - 2024
Report Coverage	Revenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Service, Phase and Region
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The US, Canada, Germany, France, UK, Italy, Spain, Japan, China, India, Australia, South Korea, and Brazil
Key Companies Profiled	SGS S.A.; Labcorp (Toxikon, Inc); American Preclinical Services; Sterigenics International LLC; Charles River Laboratories; Element Minnetonka; North America Science Associates Inc.; Eurofins Scientific; Pace Analytical Services LLC; Intertek Group Plc.
Key Market Opportunities	· Growing complexity of devices and the need for risk mitigation.
Key Market Dynamics	· Stringent regulatory requirements and standards imposed on medical device manufacturers.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

What is the projected growth of the Medical Device Testing Services market?

The Medical Device Testing Services market is the expected increase in total market value of 27.01 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Medical Device Testing Services market?

Medical Device Testing Services market size was valued at approximately 10.15 billion USD in 2024. This figure will reach 27.01 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Medical Device Testing Services market?

Medical Device Testing Services market is expected to grow at a CAGR of 9.3% between 2025 and 2035.

How much will the Medical Device Testing Services market be worth by 2035?

Medical Device Testing Services market is expected to be worth of 27.01 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Medical Device Testing Services market perform over the next 10 years?

Over the next 10 years the Medical Device Testing Services market is expected to shift from usd billion 10.15 to 27.01 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

How much is the Medical Device Testing Services market?

The Medical Device Testing Services Market size valued at USD 8.5 Billion in 2024.

Table of Contents
Executive Summary
Market Introduction
1. Definition
2. Scope of the Study
  1. Research Objective
  2. Assumptions
  3. Limitations
Research Methodology
1. Overview
2. Data Mining
3. Secondary Research
4. Primary Research
  1. Primary Interviews and Information Gathering Process
  2. Breakdown of Primary Respondents
5. Forecasting Model
6. Market Size Estimation
  1. Bottom-up Approach
  2. Top-Down Approach
7. Data Triangulation
8. Validation
MARKET DYNAMICS
1. Overview
2. Drivers
3. Restraints
4. Opportunities
MARKET FACTOR ANALYSIS
1. Value Chain Analysis
2. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
3. COVID-19 Impact Analysis
  1. Market Impact Analysis
  2. Regional Impact
  3. Opportunity and Threat Analysis
GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE
1. Overview
2. Biocompatibility Tests
3. Chemistry Test
4. Microbiology & Sterility Test
GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE
1. Overview
2. Preclinical
3. Clinical
GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY REGION
1. Overview
2. North America
  1. US
  2. Canada
3. Europe
  1. Germany
  2. France
  3. UK
  4. Italy
  5. Spain
  6. Rest of Europe
4. Asia-Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Australia
  6. Rest of Asia-Pacific
5. Rest of the World
  1. Middle East
  2. Africa
  3. Latin America
Competitive Landscape
1. Overview
2. Competitive Analysis
3. Market Share Analysis
4. Major Growth Strategy in the Global Medical Device Testing Services Market,
5. Competitive Benchmarking
6. Leading Players in Terms of Number of Developments in the Global Medical Device Testing Services Market,
7. Key developments and Growth Strategies
  1. New Product Launch/Service Deployment
  2. Merger & Acquisitions
  3. Joint Ventures
8. Major Players Financial Matrix
  1. Sales & Operating Income, 2022
  2. Major Players R&D Expenditure. 2022
COMPANY PROFILES
1. SGS SA
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
2. Labcorp
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
3. American Preclinical Services
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
4. Sterigenics International LLC
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
5. Charles River Laboratories
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
6. Element Minnetonka
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
7. North America Science Associates Inc
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
8. Eurofins Scientific
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
9. Pace Analytical Services LLC
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
10. Intertek Group Plc
  1. Company Overview
  2. Financial Overview
  3. Products Offered
  4. Key Developments
  5. SWOT Analysis
  6. Key Strategies
APPENDIX
1. References
2. Related Reports
List of Tables and Figures
1. LIST OF TABLES
2. TABLE 1 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SYNOPSIS, 2018-2034
3. TABLE 2 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, ESTIMATES & FORECAST, 2018-2034 (USD BILLION)
4. TABLE 3 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
5. TABLE 4 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
6. TABLE 5 NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
7. TABLE 6 NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
8. TABLE 7 US: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
9. TABLE 8 US: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
10. TABLE 9 CANADA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
11. TABLE 10 CANADA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
12. TABLE 1 EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
13. TABLE 2 EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
14. TABLE 3 GERMANY: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
15. TABLE 4 GERMANY: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
16. TABLE 5 FRANCE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
17. TABLE 6 FRANCE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
18. TABLE 7 ITALY: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
19. TABLE 8 ITALY: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
20. TABLE 9 SPAIN: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
21. TABLE 10 SPAIN: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
22. TABLE 11 UK: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
23. TABLE 12 UK: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
24. TABLE 13 REST OF EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
25. TABLE 14 REST OF EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
26. TABLE 15 ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
27. TABLE 16 ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
28. TABLE 17 JAPAN: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
29. TABLE 18 JAPAN: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
30. TABLE 19 CHINA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
31. TABLE 20 CHINA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
32. TABLE 21 INDIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
33. TABLE 22 INDIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
34. TABLE 23 AUSTRALIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
35. TABLE 24 AUSTRALIA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
36. TABLE 25 SOUTH KOREA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
37. TABLE 26 SOUTH KOREA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
38. TABLE 27 REST OF ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
39. TABLE 28 REST OF ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
40. TABLE 29 REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
41. TABLE 30 REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
42. TABLE 31 MIDDLE EAST: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
43. TABLE 32 MIDDLE EAST: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
44. TABLE 33 AFRICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
45. TABLE 34 AFRICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION)
46. TABLE 35 LATIN AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY SERVICE, 2018-2034 (USD BILLION)
47. TABLE 36 LATIN AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, BY PHASE, 2018-2034 (USD BILLION) LIST OF FIGURES
48. FIGURE 1 RESEARCH PROCESS
49. FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET
50. FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET
51. FIGURE 4 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY SERVICE, 2022
52. FIGURE 5 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY PHASE, 2022
53. FIGURE 6 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
54. FIGURE 7 NORTH AMERICA: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
55. FIGURE 8 EUROPE: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
56. FIGURE 9 ASIA-PACIFIC: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
57. FIGURE 10 REST OF THE WORLD: MEDICAL DEVICE TESTING SERVICES MARKET, SHARE (%), BY REGION, 2022
58. FIGURE 11 GLOBAL MEDICAL DEVICE TESTING SERVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
59. FIGURE 12 SGS SA: FINANCIAL OVERVIEW SNAPSHOT
60. FIGURE 13 SGS SA: SWOT ANALYSIS
61. FIGURE 14 LABCORP: FINANCIAL OVERVIEW SNAPSHOT
62. FIGURE 15 LABCORP: SWOT ANALYSIS
63. FIGURE 16 AMERICAN PRECLINICAL SERVICES: FINANCIAL OVERVIEW SNAPSHOT
64. FIGURE 17 AMERICAN PRECLINICAL SERVICES: SWOT ANALYSIS
65. FIGURE 18 STERIGENICS INTERNATIONAL LLC: FINANCIAL OVERVIEW SNAPSHOT
66. FIGURE 19 STERIGENICS INTERNATIONAL LLC: SWOT ANALYSIS
67. FIGURE 20 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
68. FIGURE 21 CHARLES RIVER LABORATORIES: SWOT ANALYSIS
69. FIGURE 22 ELEMENT MINNETONKA: FINANCIAL OVERVIEW SNAPSHOT
70. FIGURE 23 ELEMENT MINNETONKA: SWOT ANALYSIS
71. FIGURE 24 NORTH AMERICA SCIENCE ASSOCIATES INC: FINANCIAL OVERVIEW SNAPSHOT
72. FIGURE 25 NORTH AMERICA SCIENCE ASSOCIATES INC: SWOT ANALYSIS
73. FIGURE 26 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
74. FIGURE 27 EUROFINS SCIENTIFIC: SWOT ANALYSIS
75. FIGURE 28 PACE ANALYTICAL SERVICES LLC: FINANCIAL OVERVIEW SNAPSHOT
76. FIGURE 29 PACE ANALYTICAL SERVICES LLC: SWOT ANALYSIS
77. FIGURE 30 INTERTEK GROUP PLC: FINANCIAL OVERVIEW SNAPSHOT
78. FIGURE 31 INTERTEK GROUP PLC: SWOT ANALYSIS

Market Segmentation Tab

Medical Device Testing Services Service Outlook (USD Billion, 2018-2034)

Biocompatibility Tests
Chemistry Test
Microbiology & Sterility Test

Medical Device Testing Services Phase Outlook (USD Billion, 2018-2034)

Preclinical
Clinical

Medical Device Testing Services Regional Outlook (USD Billion, 2018-2034)

North America Outlook (USD Billion, 2018-2034)
- North America Medical Device Testing Services by Service
  - Biocompatibility Tests
  - Chemistry Test
  - Microbiology & Sterility Test
- North America Medical Device Testing Services by Phase
  - Preclinical
  - Clinical
- US Outlook (USD Billion, 2018-2034)
- US Medical Device Testing Services by Service
  - Biocompatibility Tests
  - Chemistry Test
  - Microbiology & Sterility Test
- US Medical Device Testing Services by Phase
  - Preclinical
  - Clinical
- CANADA Outlook (USD Billion, 2018-2034)
- CANADA Medical Device Testing Services by Service
  - Biocompatibility Tests
  - Chemistry Test
  - Microbiology & Sterility Test
- CANADA Medical Device Testing Services by Phase
  - Preclinical
  - Clinical
- Europe Outlook (USD Billion, 2018-2034)
  - Europe Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - Europe Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - Germany Outlook (USD Billion, 2018-2034)
  - Germany Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - Germany Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - France Outlook (USD Billion, 2018-2034)
  - France Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - France Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - UK Outlook (USD Billion, 2018-2034)
  - UK Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - UK Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - ITALY Outlook (USD Billion, 2018-2034)
  - ITALY Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - ITALY Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - SPAIN Outlook (USD Billion, 2018-2034)
  - Spain Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - Spain Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - Rest Of Europe Outlook (USD Billion, 2018-2034)
  - Rest Of Europe Medical Device Testing Services by Service
    - Biocompatibility Tests
    - Chemistry Test
    - Microbiology & Sterility Test
  - REST OF EUROPE Medical Device Testing Services by Phase
    - Preclinical
    - Clinical
  - Asia-Pacific Outlook (USD Billion, 2018-2034)
    - Asia-Pacific Medical Device Testing Services by Service
      - Biocompatibility Tests
      - Chemistry Test
      - Microbiology & Sterility Test
    - Asia-Pacific Medical Device Testing Services by Phase
      - Preclinical
      - Clinical
    - China Outlook (USD Billion, 2018-2034)
    - China Medical Device Testing Services by Service
      - Biocompatibility Tests
      - Chemistry Test
      - Microbiology & Sterility Test
    - China Medical Device Testing Services by Phase
      - Preclinical
      - Clinical
    - Japan Outlook (USD Billion, 2018-2034)
    - Japan Medical Device Testing Services by Service
      - Biocompatibility Tests
      - Chemistry Test
      - Microbiology & Sterility Test
    - Japan Medical Device Testing Services by Phase
      - Preclinical
      - Clinical
    - India Outlook (USD Billion, 2018-2034)
    - India Medical Device Testing Services by Service
      - Biocompatibility Tests
      - Chemistry Test
      - Microbiology & Sterility Test
    - India Medical Device Testing Services by Phase
      - Preclinical
      - Clinical
    - Australia Outlook (USD Billion, 2018-2034)
    - Australia Medical Device Testing Services by Service
      - Biocompatibility Tests
      - Chemistry Test
      - Microbiology & Sterility Test
    - Australia Medical Device Testing Services by Phase
      - Preclinical
      - Clinical
    - Rest of Asia-Pacific Outlook (USD Billion, 2018-2034)
    - Rest of Asia-Pacific Medical Device Testing Services by Service
      - Biocompatibility Tests
      - Chemistry Test
      - Microbiology & Sterility Test
    - Rest of Asia-Pacific Medical Device Testing Services by Phase
      - Preclinical
      - Clinical
    - Rest of the World Outlook (USD Billion, 2018-2034)
      - Rest of the World Medical Device Testing Services by Service
        Biocompatibility Tests
        Chemistry Test
        Microbiology & Sterility Test
      - Rest of the World Medical Device Testing Services by Phase
        Preclinical
        Clinical
      - Middle East Outlook (USD Billion, 2018-2034)
      - Middle East Medical Device Testing Services by Service
        Biocompatibility Tests
        Chemistry Test
        Microbiology & Sterility Test
      - Middle East Medical Device Testing Services by Phase
        Preclinical
        Clinical
      - Africa Outlook (USD Billion, 2018-2034)
      - Africa Medical Device Testing Services by Service
        Biocompatibility Tests
        Chemistry Test
        Microbiology & Sterility Test
      - Africa Medical Device Testing Services by Phase
        Preclinical
        Clinical
      - Latin America Outlook (USD Billion, 2018-2034)
      - Latin America Medical Device Testing Services by Service
        Biocompatibility Tests
        Chemistry Test
        Microbiology & Sterility Test
      - Latin America Medical Device Testing Services by Phase
        Preclinical
        Clinical

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027

Medical Device Testing Services Market Size

Medical Device Testing Services Market Research Report Information By Services (Biocompatibility Tests, Chemistry Test and Microbiology & Sterility Test), By Phase (Preclinical and Clinical) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World), Forecast Till 2035

Purchase Options

Medical Device Testing Services Size

Market Size Snapshot

Regional Deep Dive

Europe

Asia Pacific

Latin America

North America

Middle East And Africa

Did You Know?

Segmental Market Size

Future Outlook

Market Highlights

Market Summary

Key Market Trends & Highlights

Market Size & Forecast

Major Players

Market Trends

Stringent regulatory requirements and standards are driving the market growth.

U.S. Food and Drug Administration (FDA)

Medical Device Testing Services Market Market Drivers

Increasing Regulatory Compliance Requirements

Market Segment Insights

Medical Device Testing Services Service Insights

Medical Device Testing Services Phase Insights

Get more detailed insights about Medical Device Testing Services Market Research Report 2035

Regional Insights

Key Players and Competitive Insights

Key Companies in the Medical Device Testing Services Market market include

Industry Developments

Future Outlook

Medical Device Testing Services Market Future Outlook

Market Segmentation

Medical Device Testing Services Phase Outlook

Medical Device Testing Services Service Outlook

Medical Device Testing Services Regional Outlook

Report Scope

Market Highlights

Author

Leave a Comment

Latest Comments

FAQs

Market Segmentation Tab

Medical Device Testing Services Service Outlook (USD Billion, 2018-2034)

Medical Device Testing Services Phase Outlook (USD Billion, 2018-2034)

Medical Device Testing Services Regional Outlook (USD Billion, 2018-2034)

Free Sample Request

Related Reports

Customer Strories

Victoria Milne

Founder